SPARK THERAPEUTICS, INC.

biotechnology

Filings
34
Clients
1
Total Income
—
Years Active
2017–2025

Filings

Year Client Period Income Expenses Doc
2025 SPARK THERAPEUTICS, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Termination
— $100,000
2025 SPARK THERAPEUTICS, INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
— $190,000
2024 SPARK THERAPEUTICS, INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
— $250,000
2024 SPARK THERAPEUTICS, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
— $180,000
2024 SPARK THERAPEUTICS, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
— $170,000
2024 SPARK THERAPEUTICS, INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
— $210,000
2023 SPARK THERAPEUTICS, INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
— $230,000
2023 SPARK THERAPEUTICS, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
— $180,000
2023 SPARK THERAPEUTICS, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
— $190,000
2023 SPARK THERAPEUTICS, INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
— $210,000
Page 1 of 4  ·  34 filings Next

Clients Represented

ClientFilingsTotal Income
SPARK THERAPEUTICS, INC. 34 —

Lobbyists

NameDisclosed Prior Position
JEREMY ALLEN Health Policy Advisor, Rep. Bilirakis; Health Policy Coordinator, House Energy and Commerce Committee
KATHLEEN M. MCAULIFFE